Clinical Trial: Study of the blood–interstitial fluid glucose gradient for early warning and dynamic classification of skin failure in patients with sepsis (China)

Posted On: 2026-10-21

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study of the blood–interstitial fluid glucose gradient for early warning and dynamic classification of skin failure in patients with sepsis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134747

Registration Time: 2026/10/20

Type: Observational study

Primary Sponsor: Drum Tower Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341726

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study of the blood–interstitial fluid glucose gradient for early warning and dynamic classification of skin failure in patients with sepsis (China)